Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Last updated on Aug 7, 2025
Important factors affecting GLP-1 market demand and take-up include: The need for better long-term data on the safety and efficacy of use for the designated indications The rapidly expanding list of potential new indications for the drugs, including chronic kidney disease, broader cardiovascular risk reduction, metabolic liver disease, and Alzheimer's disease The number of similar drugs in the development pipeline Price point versus competition, which affects affordability and insurance coverage Marketing efforts of the manufacturers, supply and distribution constraints
The short biological half-life is due to a rapid enzymatic degradation of GLP-1 (and GIP also) by the enzyme dipeptidyl peptidase IV (DPP-4) (8)
The GLP-1 effect on MedTech
It depends on the patient, says Inge, who has operated on an 8-year-old
